News|Articles|October 2, 2002

Pharmaceutical Technology-10-02-2002
Volume 26
Issue 10

FDA Launches Major Review of CGMPs

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

External Link - article-36195.pdf

Articles in this issue

over 23 years ago

Article

Understanding Pharmaceutical Flows

over 23 years ago

Article

Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

over 23 years ago

Article

An Overview of the Validation Approach for Moist Heat Sterilization, Part II

over 23 years ago

Article

Cyclodextrins as Sustained-Release Carriers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer

ByBrian Drapeau

June 16th 2026

Concept image of the six most common questions | Image Credit: © RTimages - stock.adobe.com

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

ByChristopher Cole

November 19th 2025

Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two

ByPatrick Lavery

November 7th 2025

How 100% Pharmaceutical Tariffs Will Impact Domestic Manufacturing and Supply Chains

ByChristopher Cole

September 26th 2025

Close-up of Medical Ampoule Production Line at Modern Modern Pharmaceutical Factory. Glass Ampoules are being Filled. Medication Manufacturing Process. | Image Credit: © IM Imagery - stock.adobe.com

Stakeholders React to FDA's Push for Quality, Integrity, and Uniformity

ByPatrick Lavery

September 24th 2025

FDA Launches Major Review of CGMPs

Articles in this issue

Related Content

Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer

The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program

Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two

How 100% Pharmaceutical Tariffs Will Impact Domestic Manufacturing and Supply Chains

Stakeholders React to FDA's Push for Quality, Integrity, and Uniformity

Trending on Pharmaceutical Technology

FDA Updates Master Protocol: What Developers Need to Know

Pharma Fundamentals: Hold Times in Biopharmaceuticals

Merck KGaA Launches Saturnus Bio; Announces Awards

IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires

FDA Approves Pfizer’s Breast Cancer Treatment